BIOCRYST PHARMACEUTICALS INC (BCRX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BCRX. The 7-day demo opens the 1M and 3M ranges and puts BCRX on your watchlist.
Start 7-day demoLatest BCRX insider trades
About BIOCRYST PHARMACEUTICALS INC (BCRX)
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
- DURHAM, NC
- 435
- 1994
- XNAS
BCRX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 5,023 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BCRX insider transactions (Form 4)
565 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Helen M. Thackray - Officer | Tax withholding / forfeiture | Common Stock | 7,150 | $7.53 | $54K | |
| Alane P. Barnes - Officer | Tax withholding / forfeiture | Common Stock | 8,613 | $7.53 | $65K | |
| Jon P. Stonehouse - Officer | Tax withholding / forfeiture | Common Stock | 27,525 | $7.53 | $207K | |
| Nancy J. Hutson - Director | Open-market sale | Common Stock | 7,000 | $7.54 | $53K | |
| Vincent Milano - Director | Grant or award | Common Stock | 750 | $7.50 | $6K |
Recent BCRX Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
Stock trades in BCRX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
BCRX insider trading FAQ
What is the latest insider trade for BCRX?
BIOCRYST PHARMACEUTICALS INC (BCRX) had 5 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for BCRX runs to 65 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BCRX stock?
No insider purchases of BCRX were filed in the last 90 days.
How many insiders are selling BCRX stock?
No insider sales of BCRX were filed in the last 90 days. 12 sales are on record for this company.
Where can I see BCRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BCRX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jon P. Stonehouse view on EDGAR
- - Jill C. Milne view on EDGAR
- - Vincent Milano view on EDGAR
- - Amy E. McKee view on EDGAR
- - Steven Frank view on EDGAR
- - Jill C. Milne view on EDGAR
- - Steven K. Galson view on EDGAR
- - Alan G. Levin view on EDGAR
- - Steven Frank view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BCRX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BCRX with a 7-day demo
- BCRX on your watchlist
- Every BCRX Form 4 filing on record
- Up to 3 months of BCRX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
